Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Esophageal Squamour Cell Cancer × palbociclib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Rare Tumour 1 Nasopharyngeal Carcinoma 1 Kidney Neoplasms 1 Esophageal Squamour Cell Cancer 1 Advanced Breast Cancer 1

Interventions

palbociclib 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07191977 2025-09-25

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma

West China Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamour Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡